Quince Therapeutics
$30.60
64
+$1.06+3.59% 14:43 Today
Statistics
Day High
30.65
Day Low
29.92
52W High
910
52W Low
15.1
Volume
6,138
Avg. Volume
57,118
Mkt Cap
29.93M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
11AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-28.02
6.52
41.06
75.6
Expected EPS
-28.02
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-83.98MNet Income
Analyst Ratings
30.00Average Price Target
The highest estimate is 82.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow QNCX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.25B
Editas Medicine
EDIT
Mkt Cap500.29M
Intellia Therapeutics
NTLA
Mkt Cap1.99B
Voyager Therapeutics
VYGR
Mkt Cap207.85M
Protagonist Therapeutics
PTGX
Mkt Cap8.45B
Fate Therapeutics
FATE
Mkt Cap361.33M
Regenxbio
RGNX
Mkt Cap721.18M
About
Quince Therapeutics, Inc. (QNCX) operates as a biopharmaceutical firm dedicated to developing targeted treatments for debilitating and rare diseases. A cornerstone of their innovation is an extensive bone-targeting drug delivery platform, engineered to accurately transport diverse therapeutic agents, such as small molecules, peptides, and large molecules, directly to affected bone areas like fractures and disease sites. Leading their pipeline is NOV004, an anabolic peptide meticulously designed to pinpoint and accumulate its therapeutic action precisely at bone fracture locations. The company, previously known as Cortexyme, Inc., officially rebranded as Quince Therapeutics, Inc. in August 2022. Established in 2012, Quince Therapeutics is headquartered in South San Francisco, California.
Show more...
CEO
Dr. Dirk Thye M.D.
Employees
38
Country
United States
ISIN
US22053A3059
Listings
0 Comments
Share your thoughts
FAQ
What is Quince Therapeutics stock price today?▼
The current price of QNCX is $30.60 USD — it has increased by +3.59% in the past 24 hours. Watch Quince Therapeutics stock price performance more closely on the chart.
What is Quince Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Quince Therapeutics stocks are traded under the ticker QNCX.
Is Quince Therapeutics stock price growing?▼
QNCX stock has risen by +30.4% compared to the previous week, the month change is a +74.29% rise, over the last year Quince Therapeutics has showed a -90.87% decrease.
What is Quince Therapeutics market cap?▼
Today Quince Therapeutics has the market capitalization of 29.93M
When is the next Quince Therapeutics earnings date?▼
Quince Therapeutics is going to release the next earnings report on August 11, 2026.
What were Quince Therapeutics earnings last quarter?▼
QNCX earnings for the last quarter are 75.6 USD per share, whereas the estimation was -26 USD resulting in a +390.77% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Quince Therapeutics revenue for the last year?▼
Quince Therapeutics revenue for the last year amounts to 0 USD.
What is Quince Therapeutics net income for the last year?▼
QNCX net income for the last year is -83.98M USD.
How many employees does Quince Therapeutics have?▼
As of August 07, 2026, the company has 38 employees.
In which sector is Quince Therapeutics located?▼
Quince Therapeutics operates in the Health & Wellness sector.
When did Quince Therapeutics complete a stock split?▼
The last stock split for Quince Therapeutics was on June 30, 2026 with a ratio of 1:20.
Where is Quince Therapeutics headquartered?▼
Quince Therapeutics is headquartered in South San Francisco, United States.